ABATTIS ANNOUNCES THE OFFICIAL LAUNCH OF NORTHERN VINE LABORATORY
May 3, 2017
|
Abattis Bioceuticals Corp. l Vancouver, BC
Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine”), has officially launched its flagship laboratory, having completed its first successful test analysis.
"I am very pleased to announce this significant milestone in our Company's development," said Robert Abenante, President and CEO of Abattis and Northern Vine. "I am proud of our dedicated team for working diligently to make this day a reality."
Northern Vine obtained a Health Canada Dealers’ License pursuant to the provisions of the Controlled Drugs and Substances Act and the Narcotic Control Regulations. On November 30, 2016, the Task Force on Cannabis Legalization and Regulation published a report which emphasized the importance of independent lab testing of all cannabis products.
“As Canada continues down the path to legalizing medical and recreational marijuana, quality regulation and health awareness are becoming mo... |